Skip to main content
logo
Aspen Neuroscience, Inc. (ASPE)
Aspen Neuroscience will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Aspen Neuroscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending
TTMDec '25 Dec '24
Cash & Equivalents
21.2982.115.22
Short-Term Investments
51.0928.642.46
Cash & Cash Equivalents
72.38110.757.68
Cash Growth
-91.91%-
Other Current Assets
2.221.691.91
Total Current Assets
74.6112.3959.59
Property, Plant & Equipment
-18.912.29
Goodwill and Intangibles
-8.5310.85
Other Long-Term Assets
-3.857.48
Total Long-Term Assets
-31.2830.62
Total Assets
-143.6690.21

Liabilities

Year Ending
TTMDec '25 Dec '24
Accounts Payable
-2.640.85
Current Debt
-3.533.43
Other Current Liabilities
16.358.099.76
Total Current Liabilities
16.3514.2614.04
Long-Term Debt
-7.6710.4
Other Long-Term Liabilities
-00.02
Total Long-Term Liabilities
-7.6710.42
Total Liabilities
-21.9324.46

Shareholders' Equity

Year Ending
TTMDec '25 Dec '24
Retained Earnings
--228.34-166.28
Comprehensive Income
-0.010.04
Shareholders' Equity
-251.07-217.08-157.73

Additional Metrics

Year Ending
TTMDec '25 Dec '24
Total Debt
9.7711.213.83
Debt Growth
--19.00%-
Net Cash (Debt)
62.6199.543.85
Net Cash (Debt) Growth
-126.89%-
Working Capital
58.2498.1245.55